Archives
-
3-Deazaneplanocin (DZNep) Workflow Guide
2026-09-15
3-Deazaneplanocin (DZNep) links S-adenosylhomocysteine hydrolase inhibition with EZH2-associated epigenetic remodeling, making it useful for mechanism-led cancer and metabolic disease assays. This guide translates that activity into practical workflows for apoptosis induction in AML cells, cancer stem cell targeting, and hepatocellular carcinoma research, with built-in controls and troubleshooting steps.
-
GKT137831: A Redox-to-Ferroptosis Assay Framework
2026-09-15
GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, offers a rigorous way to connect ROS generation with plasma-membrane failure. This article translates recent ferroptosis findings into practical assay design for vascular, fibrotic, and oxidative-stress research.
-
Tetrazolium Red: From Viability Signal to Translation
2026-09-14
Tetrazolium (chloride), also known as Tetrazolium Red or TTC, is more than a colorimetric reagent: it is a functional bridge between mitochondrial redox activity, tissue viability, and translational decision-making. This article places TTC staining in the mechanistic context of oxidative injury and cardamomin-mediated protection in cerebral ischemia, while outlining practical strategies for producing more decision-ready data.
-
CUX2 Neuron Loss from DNA Damage in Neuroinflammation
2026-09-14
The reference study identifies accumulated DNA damage and inadequate double-strand break repair as drivers of selective CUX2-positive layer 2/3 excitatory neuron loss during neuroinflammation. By integrating human multiple sclerosis tissue, mouse models, genetic analyses, and interferon-γ exposure, it connects neuronal subtype vulnerability to CUX2, ATF4, reactive oxygen species, and DNA repair capacity.
-
EdU Flow Cytometry Assay Kits (Cy5) Workflow
2026-09-13
EdU Flow Cytometry Assay Kits (Cy5) provide a denaturation-free way to quantify DNA synthesis during S phase using EdU incorporation and Cy5 click-chemistry detection. They are intended for research flow cytometry workflows, including proliferation, genotoxicity, and pharmacodynamic studies, rather than clinical diagnostics, in vivo labeling, or tissue imaging.
-
GS-441524: A Matrix-Aware Assay Strategy
2026-09-12
GS-441524 research is most informative when parent compound, prodrug, and active metabolite are measured as distinct analytical entities. This matrix-aware guide translates recent LC–MS/MS findings into practical decisions for antiviral assays and pharmacokinetic studies.
-
GS-441524: From Nucleoside to Translational Strategy
2026-09-11
GS-441524 is more than a single antiviral test article: it is a platform for studying nucleoside activation, prodrug conversion, matrix-specific exposure, and translational pharmacokinetics. New LC–MS/MS findings on the NGP-1 GS-441524 prodrug show why researchers should measure parent and metabolite together rather than infer biological performance from nominal dosing alone.
-
ARCA EGFP mRNA (5-moUTP): Assay Design
2026-09-11
ARCA EGFP mRNA (5-moUTP) enables direct, fluorescence-based assessment of mRNA transfection in mammalian cells. This guide goes beyond product features to explain how cap orientation, nucleotide modification, storage control, and assay architecture shape the reliability of EGFP readouts.
-
Substance P: Analytical Controls for Better Research
2026-09-10
Substance P is more than a pain-model agonist: it is a precise tool for studying neuroimmune signaling when identity, handling, and assay interference are controlled. This guide connects NK-1 biology with lessons from modern fluorescence-spectroscopy quality control.
-
Concanamycin A: Reliable V-ATPase Assays
2026-09-10
Learn how Concanamycin A (SKU A8633) can improve the interpretation and reproducibility of cell viability, apoptosis, trafficking, and invasion experiments. This scenario-based guide connects concentration, vehicle, timing, controls, and product-format decisions to evidence-informed cancer biology workflows.
-
HACC-TNF-α-VLPs Enhance FMDV Cross-Presentation
2026-09-09
This 2026 study developed HACC-TNF-α-VLP nanoparticles that improved dendritic-cell antigen cross-presentation through an HSP90-associated mechanism. In mice, the formulation strengthened CD8+ T-cell, tissue-resident memory, mucosal IgA, and systemic antibody responses, providing a technically informative framework for next-generation foot-and-mouth disease vaccines.
-
TG003 and CLK2: From Splicing to Translation
2026-09-09
TG003 offers a mechanistically useful bridge between Clk-dependent splicing control and CLK2-linked platinum resistance. This thought-leadership guide outlines how translational researchers can use the compound to separate kinase, splicing, and DNA-repair hypotheses without overstating a research tool as a clinical therapy.
-
Mifepristone (RU486): From PR Antagonism to Translation
2026-09-08
Mifepristone (RU486) is more than a progesterone receptor antagonist: it is a mechanistic probe for connecting hormone-receptor context, cell-cycle control, ferroptosis, and reproductive biology. This thought-leadership analysis outlines how translational researchers can use the compound strategically while distinguishing established evidence from hypothesis-generating opportunities.
-
Nirmatrelvir (PF-07321332) Lab Assays
2026-09-08
Learn how Nirmatrelvir (PF-07321332), SKU B8579, can support reproducible SARS-CoV-2 protease and cell-based antiviral experiments. This scenario-driven guide covers assay interpretation, solvent compatibility, stock preparation, controls, and practical supplier selection.
-
Capsaicin as a KDM1A/LSD1 Inhibitor
2026-09-07
Jia and colleagues identified Capsaicin as a reversible, FAD-competitive inhibitor of lysine-specific demethylase 1A (KDM1A/LSD1), extending the biological scope of this dietary vanillamide beyond sensory pharmacology. In gastric cancer cells, the study connected KDM1A inhibition with reduced migration and invasion and reversal of epithelial–mesenchymal transition, while also highlighting important limits for target validation and cross-domain interpretation.